Variability in LPS composition, antigenicity and reactogenicity of phase variants of Bordetella pertussis.
Comparison of lipopolysaccharides (LPS) from phase variants of different strains of Bordetella phase variants of different strains of Bordetella pertussis has shown a difference in their composition, antigenicity and reactogenicity. Phase I variants of B. pertussis, with the exception of strain 134, contain a preponderance of LPS I whereas the major component of LPS of phase IV variants is LPS II. Sera raised to LPSs of phase I strains, other than 134, cross-react with each other but not with phase IV LPSs; and similarly all sera raised to phase IV LPSs cross-react with each other and with LPS from 134 phase I. The LPSs of all phase I variants, including that of 134, are approximately ten-fold or more reactive in the limulus amoebocyte lysate assay (LAL) than phase IV LPSs. In the human mononuclear cell pyrogen assay phase IV LPSs also stimulated a lower response than phase I LPSs. The B. pertussis phase I LPSs are 10-times more reactive than Escherichia coli standard endotoxin in the LAL assay but 100-times less reactive than E. coli LPS in the monocyte test for pyrogen. The SDS-PAGE profiles of B. pertussis LPSs are quite different from those of B. parapertussis and B. bronchiseptica strains. B. pertussis LPSs produced a typical lipo-oligosaccharide (LOS) pattern. B. bronchiseptica LPS produced a similar pattern but was antigenically distinct from B. pertussis LPSs I and II. B. parapertussis in contrast produced a ladder pattern typical of smooth type LPS.
Ray
A
A
Division of Bacteriology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, U.K.
Redhead
K
K
Selkirk
S
S
Poole
S
S
D000818:Animals; D001886:Bordetella pertussis / Q000032:analysis* / Q000254:growth & development / Q000276:immunology; D003429:Cross Reactions; D004591:Electrophoresis, Polyacrylamide Gel; D004731:Endotoxins / Q000032:analysis*; D004926:Escherichia coli / Q000378:metabolism; D006801:Humans; D015151:Immunoblotting; D008033:Limulus Test; D008070:Lipopolysaccharides / Q000737:chemistry* / Q000276:immunology / Q000633:toxicity; D051379:Mice; D009000:Monocytes / Q000378:metabolism; D011749:Pyrogens / Q000032:analysis
D004731:Endotoxins; D008070:Lipopolysaccharides; D011749:Pyrogens